KR860001338B1 - 4-아로일이미다졸-2-온의 제조방법 - Google Patents

4-아로일이미다졸-2-온의 제조방법 Download PDF

Info

Publication number
KR860001338B1
KR860001338B1 KR8200715A KR820000715A KR860001338B1 KR 860001338 B1 KR860001338 B1 KR 860001338B1 KR 8200715 A KR8200715 A KR 8200715A KR 820000715 A KR820000715 A KR 820000715A KR 860001338 B1 KR860001338 B1 KR 860001338B1
Authority
KR
South Korea
Prior art keywords
imidazol
dihydro
straight
carbon atoms
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR8200715A
Other languages
English (en)
Korean (ko)
Other versions
KR830009045A (ko
Inventor
에이 · 슈네틀러 리차드
시 · 데이지 리챠드
· 마르틴 그라자 제이
Original Assignee
죠셉 지 · 템플
메렐 다우 파마슈티칼스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 죠셉 지 · 템플, 메렐 다우 파마슈티칼스 인코포레이티드 filed Critical 죠셉 지 · 템플
Publication of KR830009045A publication Critical patent/KR830009045A/ko
Application granted granted Critical
Publication of KR860001338B1 publication Critical patent/KR860001338B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Luminescent Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR8200715A 1981-02-18 1982-02-18 4-아로일이미다졸-2-온의 제조방법 Expired KR860001338B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23545381A 1981-02-18 1981-02-18
US235453 1981-02-18

Publications (2)

Publication Number Publication Date
KR830009045A KR830009045A (ko) 1983-12-17
KR860001338B1 true KR860001338B1 (ko) 1986-09-15

Family

ID=22885573

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8200715A Expired KR860001338B1 (ko) 1981-02-18 1982-02-18 4-아로일이미다졸-2-온의 제조방법

Country Status (18)

Country Link
EP (1) EP0058435B1 (cg-RX-API-DMAC7.html)
JP (1) JPS57150668A (cg-RX-API-DMAC7.html)
KR (1) KR860001338B1 (cg-RX-API-DMAC7.html)
AT (1) ATE24496T1 (cg-RX-API-DMAC7.html)
AU (1) AU558789B2 (cg-RX-API-DMAC7.html)
CA (1) CA1173047A (cg-RX-API-DMAC7.html)
DE (1) DE3274855D1 (cg-RX-API-DMAC7.html)
DK (1) DK161250C (cg-RX-API-DMAC7.html)
ES (1) ES509636A0 (cg-RX-API-DMAC7.html)
GB (1) GB2093031B (cg-RX-API-DMAC7.html)
GR (1) GR76025B (cg-RX-API-DMAC7.html)
HK (1) HK61586A (cg-RX-API-DMAC7.html)
IE (1) IE52422B1 (cg-RX-API-DMAC7.html)
IL (1) IL65010A0 (cg-RX-API-DMAC7.html)
MY (1) MY8600710A (cg-RX-API-DMAC7.html)
NZ (1) NZ199733A (cg-RX-API-DMAC7.html)
PH (1) PH18106A (cg-RX-API-DMAC7.html)
ZA (1) ZA82969B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
ZA826501B (en) * 1982-09-06 1984-04-25 Du Pont Anti-hypertensive imidazole derivative
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
EP1737448A1 (en) * 2004-03-22 2007-01-03 Myogen, Inc. (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
JP2007530566A (ja) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド （ｒ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
CN117105827A (zh) * 2017-03-27 2023-11-24 魁北克电力公司 用于电解质组合物中或用作电极添加剂的盐

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions

Also Published As

Publication number Publication date
PH18106A (en) 1985-03-21
DK161250C (da) 1991-12-09
AU8048682A (en) 1982-08-26
CA1173047A (en) 1984-08-21
KR830009045A (ko) 1983-12-17
JPS57150668A (en) 1982-09-17
ES8307002A1 (es) 1983-07-01
IE820333L (en) 1982-08-18
ES509636A0 (es) 1983-07-01
HK61586A (en) 1986-08-29
IL65010A0 (en) 1982-04-30
GR76025B (cg-RX-API-DMAC7.html) 1984-08-03
EP0058435A2 (en) 1982-08-25
EP0058435A3 (en) 1984-03-21
NZ199733A (en) 1985-05-31
ATE24496T1 (de) 1987-01-15
DK67582A (da) 1982-08-19
DK161250B (da) 1991-06-17
DE3274855D1 (de) 1987-02-05
GB2093031B (en) 1984-10-24
IE52422B1 (en) 1987-10-28
ZA82969B (en) 1983-09-28
AU558789B2 (en) 1987-02-12
JPH048421B2 (cg-RX-API-DMAC7.html) 1992-02-17
EP0058435B1 (en) 1986-12-30
MY8600710A (en) 1986-12-31
GB2093031A (en) 1982-08-25

Similar Documents

Publication Publication Date Title
CA1132554A (en) 4-aroylimidazol-2-ones
US4405635A (en) 4-Aroylimidazol-2-ones and their use as pharmaceuticals
EP0011399A1 (en) N-substituted theophyllines, processes for their preparation and pharmaceutical compositions containing them
GB1584296A (en) 2-substituted benzimidazole compounds
EP0058435B1 (en) Novel 4-aroylimidazol-2-ones
CA1112641A (en) 2,6-diaminonebularines
JPH0223548B2 (cg-RX-API-DMAC7.html)
US4192880A (en) 2-Substituted benzimidazole compounds
EP0079050B1 (en) 4-aroylimidazolidin-2-ones
US3962237A (en) 1 (h)-1,2,4-triazole derivatives
KR100192647B1 (ko) 3-아릴-5-알킬티오-4h-1,2,4,-트리아졸을 함유하는 척추 손상으로 인한 반사이상항진 치료용의 약제학적 조성물
EP0078546B1 (en) Novel imidazolecarboxamide derivatives
NL7907783A (nl) Verbindingen met contraceptieve werking en preparaten die ze bevatten
US4110456A (en) 4-substituted-2-arylimidazoles
JPH0414111B2 (cg-RX-API-DMAC7.html)
EP0329691B1 (en) Cardiotonic imidazolylphenylpyrrol-2-ones
EP0197533B1 (en) Dioxolobenzisoxazole derivatives and process for preparing the same
EP0169164A1 (en) Imidazolonecarbonylarylimidazoles; method of manufacture, method of use and compositions useful thereof
AU642746B2 (en) Process for the preparation of pyrimidine nucleosides
FI61881C (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara alkansulfonater av 2-metyl-3-hydroxi-4-hydroximetyl-5-merkaptometylpyridin
JPS634556B2 (cg-RX-API-DMAC7.html)
MC1393A1 (fr) Nouveaux derives de l'imidazole
NO152218B (no) Nye tricykliske orto-sammensluttede nitrogenholdige forbindelser med fertilitetsregulerende virkning
PL219424B1 (pl) Estry etylowe kwasów 2-(4-okso-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazyn-3-ylo)octowych, sposób ich otrzymywania i zastosowanie medyczne
BE886513A (fr) Derives de l'ergoline, procede pour les preparer et leur emploi comme medicaments

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19820218

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19820517

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19820218

Comment text: Patent Application

PG1501 Laying open of application
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19860122

Patent event code: PE09021S01D

PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19860819

PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19861126

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19861203

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19861203

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19890614

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19900614

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19910603

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19920604

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19930615

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 19940609

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 19950620

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 19960701

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 19970704

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 19980708

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 19990709

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20000707

Start annual number: 15

End annual number: 15

PR1001 Payment of annual fee

Payment date: 20011010

Start annual number: 16

End annual number: 16

PC1801 Expiration of term